PATENT CLAIM ANALYSIS

Application Number: 15769844
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "227800"]

Abstract:
A compound represented by general formula [I] wherein X represents N or the like, Y represents CH or the like; R A  represents a cycloalkyl group which may be substituted or the like, R 1  represents an alkyl group or the like, R 2  represents an alkyl group which may be substituted or the like, R 3  represents a hydrogen atom or an alkyl group, or a pharmaceutically acceptable salt thereof has an inhibitory activity on aldosterone synthetase, and is useful as a prophylactic and/or therapeutic agent for various diseases or symptoms associated with aldosterone.

Claim (Index 18):
The pharmaceutical composition according to  claim 15 , wherein secondary aldosteronism is hypertension caused by an estrogen preparation, renal vascular hypertension, pregnancy hypertension, malignant hypertension, pheochromocytoma, congestive heart failure, pseudohypoaldosteronism, chronic liver disease associated with ascites, inappropriate use of a medicament such as a laxative and a diuretic, or hyperaldosteronemia associated with nephrotic syndrome, Bartter's syndrome or Gitelman syndrome.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15305587', '15313407', '15779435', '10583796', '13508905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972976680808741
- 35 USC 102 Novelty (BERT): 0.5533607836281033
- Combined Prediction Score: 0.772903979635597
- Mean Citation Score: 322.9079480000001
- Max Citation Score: 436.3854
- Similarity Product: 301.70112544505594

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test